Skip to main content Back to Top
Advertisement

5/26/2021

Dexmedetomidine Hydrochloride 4 mcg/mL Premix for Injection

Reason for the Shortage

    • Amneal has dexmedetomidine premixes available.
    • Baxter has dexmedetomidine premixes available.
    • Dr. Reddy's has dexmedetomidine premixes available.
    • Fresenius Kabi had dexmedetomidine premixes on shortage due to increased demand.
    • Slayback had dexmedetomidine premixes on shortage due to increased demand.
    • WG Critical Care had dexmedetomidine premixes on shortage due to increased demand.
    • Pfizer had Precedex on shortage due to increased demand.

Available Products

    • Precedex solution for injection, Pfizer, 4 mcg/mL, 100 mL glass bottle, 10 count, NDC 00409-1660-10
    • Precedex solution for injection, Pfizer, 4 mcg/mL, 20 mL glass vial, 10 count, NDC 00409-1660-20
    • Precedex solution for injection, Pfizer, 4 mcg/mL, 250 mL glass bottle, 1 count, NDC 00409-1434-01
    • Precedex solution for injection, Pfizer, 4 mcg/mL, 50 mL glass bottle, 20 count, NDC 00409-1660-50
    • Dexmedetomidine hydrochloride solution for injection, Amneal, 4 mcg/mL, 100 mL glass bottle, 10 count, NDC 70121-1389-07
    • Dexmedetomidine hydrochloride solution for injection, Amneal, 4 mcg/mL, 50 mL glass bottle, 20 count, NDC 70121-1388-08
    • Dexmedetomidine hydrochloride solution for injection, Baxter, 4 mcg/mL, 100 mL premixed bag, 12 count, NDC 00338-9557-12
    • Dexmedetomidine hydrochloride solution for injection, Baxter, 4 mcg/mL, 50 mL premixed bag, 24 count, NDC 00338-9555-24
    • Dexmedetomidine hydrochloride solution for injection, Dr. Reddy's, 4 mcg/mL, 100 mL glass bottle, 10 count, NDC 43598-0976-58
    • Dexmedetomidine hydrochloride solution for injection, Dr. Reddy's, 4 mcg/mL, 50 mL glass bottle, 10 count, NDC 43598-0975-58
    • Dexmedetomidine hydrochloride solution for injection, Fresenius Kabi, 4 mcg/mL, 100 mL glass bottle, 10 count, NDC 63323-0671-00
    • Dexmedetomidine hydrochloride solution for injection, Fresenius Kabi, 4 mcg/mL, 20 mL vial, 10 count, NDC 63323-0671-20
    • Dexmedetomidine hydrochloride solution for injection, Fresenius Kabi, 4 mcg/mL, 50 mL glass bottle, 25 count, NDC 63323-0671-50
    • Dexmedetomidine hydrochloride solution for injection, Slayback Pharma, 4 mcg/mL, 100 mL bottle, 10 count, NDC 71225-0126-06
    • Dexmedetomidine hydrochloride solution for injection, Slayback Pharma, 4 mcg/mL, 50 mL bottle, 20 count, NDC 71225-0126-05
    • Dexmedetomidine hydrochloride solution for injection, WG Critical Care, 4 mcg/mL, 100 mL premixed bag, 24 count, NDC 44567-0603-24
    • Dexmedetomidine hydrochloride solution for injection, WG Critical Care, 4 mcg/mL, 50 mL premixed bag, 24 count, NDC 44567-0602-24

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated May 26, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 6, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.

ADVERTISEMENT